Toronto Dominion Bank’s Lexaria Bioscience LEXX Stock Holding History

Toronto Dominion Bank’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.1K	Sell	6,668 -2,666	-29%	-$28.9K	﹤0.01%	1883
2026 Q1	$109K	Hold	9,334	–	–	﹤0.01%	1667
2025 Q4	$86.5K	Hold	9,334	–	–	﹤0.01%	1587
2025 Q3	$133K	Buy	9,334 +459	+5%	+$6.66K	﹤0.01%	1456
2025 Q2	$116K	Buy	8,875 +207	+2%	+$3.56K	﹤0.01%	1365
2025 Q1	$222K	Buy	+8,668	New	+$221K	﹤0.01%	1250
2024 Q3	–	Sell	-1	Closed	-$36	–	1318
2024 Q2	$36	Hold	1	–	–	﹤0.01%	1403
2024 Q1	$47	Hold	1	–	–	﹤0.01%	1374
2023 Q4	$16	Hold	1	–	–	﹤0.01%	1548
2023 Q3	$13	Hold	1	–	–	﹤0.01%	1800
2023 Q2	$0	Hold	1	–	–	﹤0.01%	1657
2023 Q1	$0	Buy	+1	New	+$43	﹤0.01%	1599

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Toronto Dominion Bank's LEXX Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Lexaria Bioscience (LEXX) stake by 29% in Q2 2026, selling an estimated $28.9K and leaving 6,668 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Toronto Dominion Bank first reported a position in LEXX in Q1 2023 and has held it in 12 quarters since. The position peaked at $222K in Q1 2025. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

Toronto Dominion Bank held 6,668 shares of Lexaria Bioscience worth $56.1K as of Q2 2026.
Toronto Dominion Bank sold 2,666 Lexaria Bioscience shares in Q2 2026, an estimated $28.9K.
Lexaria Bioscience made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1883 holding.
Toronto Dominion Bank first reported a position in Lexaria Bioscience in Q1 2023 and has held it in 12 quarters since.
Toronto Dominion Bank's Lexaria Bioscience position peaked at $222K in Q1 2025.
29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.